Arena Pharmaceuticals News

Weight loss drug makers rise after AMA calls obesity a disease Makers of anti-obesity drugs are advancing after the American Medical Association designated obesity as a disease.

Some biotechnology firms have had one heck of a 2013 thus far: Clovis Oncology Inc. presented monster data for their cancer drug at ASCO and saw its' shares explode as much as 130% overnight.

Arena Pharmaceuticals has a new drug that recently had its label approved by the DEA.

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns.

Association of Changes in Glycemic- and Lipid-Related Cardiometabolic Risk Factors and Weight Loss in Pooled Lorcaserin Phase 3 Studies of Obese and Overweight Patients Without Diabetes Poster session/number: SAT 660-676-Clinical Obesity Treatment, SAT-665 BELVIQ is believed to decrease food consumption and promote satiety by selectively activating ... (more)

A live audio webcast of the presentation will be available under the investor relations section of Arena's website at www.arenapharm.com .

Contrary to the expectations and hopes of many, prevailing circumstances strongly suggest that speculators hanging their hats on a buyout of Arena Pharmaceuticals will be sorely disappointed.

Arena Pharmaceuticals has hit a consumer watchdog snag in the launch week of the anti-obesity drug Belviq.

Arena Pharmaceuticals has been through a series of normal and not so normal influences between the bulls and the bears.

Give yourself an advantage in today's market. In order to become successful, you need to have information as it happens and understand how it plays out into future stock price.

With a high cost and only marginal benefits, the new weight loss drug may not be helpful to a majority of people.

Arena Pharmaceuticals has finally launched its long awaited novel weight loss drug, Belviq, with the help of pharmaceutical company Eisai, and the excitement about the immense potential for Arena shareholders and tension between ARNA bulls and bears has never been higher.

's stock had its "overweight" rating reiterated by Piper Jaffray in a research note issued on Tuesday, AnalystRatings.Net reports.

After setting off a storm of criticism from abortion rights groups upset that a Democratic president had sided with social conservatives, the Obama administration said it will comply with a judge's order to allow girls of any age to buy emergency contraception without prescriptions.

Arena Pharmaceuticals says its weight loss drug Belviq will be available to U.S. patients beginning next week, nearly a year after the drug was officially approved by federal regulators.

A bill that is intended to persuade more Oregon parents to take their kids to doctors for shots and get over their mistrust of conventional medicine has taken a big step in the Legislature with passage by the state... A bill that is intended to persuade more Oregon parents to take their kids to doctors for shots and get over their mistrust of ... (more)

A few months ago, Eisai , marketing partner to Arena Pharmaceuticals on the anti-obesity drug Belviq, established a wholesale price of $200 per month for a prescription.

It took considerably longer than it does to weigh and measure an approved Weight Watchers meal, but prescription weight loss drug Belviq finally will become available to United States patients next week, reported the Associated Press on June 7. A year ago, the Food and Drug Administration approved the drug for adults with serious medical conditions ... (more)

Federal health experts are recommending changes to safety restrictions on former blockbuster diabetes pill Avandia, in light of a new analysis suggesting that the drug may not increase the risk of heart attack as previously believed.

Arena Pharmaceuticals says its weight loss drug Belviq will be available to U.S. patients beginning next week, nearly a year after the drug was officially approved by federal regulators.